The identification of more XIAP-mutant patients in the following years prompted clinicians to classify XIAP deficiency-caused disease as familial HLH (FHHL) or XLP2 [102] (Table 1). This evidence concerns the gene XIAP and hyperinsulinemic hypoglycemia, familial, 4.